サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1413718

組織バンクの世界市場、予測（～2030年）

Tissue Banking Market Research Report Forecast till 2030

出版日
ページ情報
英文 160 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
組織バンクの世界市場、予測（～2030年）
出版日: 2024年01月15日
発行: Market Research Future
ページ情報: 英文 160 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の組織バンキングの市場規模は、調査期間にCAGRで8.5%の堅調に成長すると予測されています。

地域の考察

先進技術へのアクセス性、医療枠組みの拡大、北米地域における組織バンクの発展を後押しする金融情勢などにより、北米が2022年に最大の市場シェアを占めるました。

研究開発運動の高まりなどにより、欧州市場が第2位の市場シェアを占める見込みです。地域における臓器提供者数の増加も、組織バンクの発展を促進しています。

アジア太平洋市場は、調査期間にCAGRで6.90%で成長すると予測されています。

当レポートでは、世界の組織バンク市場について調査分析し、市場力学、地域とセグメントの分析、企業プロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

  • 市場の魅力分析
    • 世界の組織バンク市場：タイプ別
    • 世界の組織バンク市場：組織タイプ別
    • 世界の組織バンク市場：用途別
    • 世界の組織バンク市場：地域別

第2章 市場のイントロダクション

第3章 調査手法

第4章 市場力学

  • イントロダクション
  • 促進要因
  • 抑制要因
  • 機会

第5章 市場要因の分析

  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
    • 市場に対する影響分析
    • 地域に対する影響
    • 機会と脅威の分析

第6章 世界の組織バンク市場：タイプ別

  • 概要
  • 培地、消耗品
  • 冷凍保存装置
  • 解凍装置
  • 品質管理装置
  • その他

第7章 世界の組織バンク市場：組織タイプ別

  • 概要
  • 心臓弁
  • 角膜
  • 骨
  • 肌
  • 脳・脊髄
  • その他

第8章 世界の組織バンク市場：用途別

  • 概要
  • 治療
  • 医学研究
  • その他

第9章 世界の組織バンク市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • その他の地域
    • 中東
    • アフリカ
    • ラテンアメリカ

第10章 競合情勢

  • イントロダクション
  • 競合分析
  • 市場シェア分析
  • 世界の組織バンク市場における主な成長戦略
  • 競合ベンチマーキング
  • 世界の組織バンク市場における開発数の主要企業
  • 主な発展と成長戦略
    • 新製品の発売
    • 合併と買収
    • 合弁事業
  • 主要企業の財務マトリクス
    • 売上と営業利益（2022年）
    • 主要企業の研究開発支出（2022年）

第11章 企業プロファイル

  • THERMO FISHER SCIENTIFIC INC
  • BIOLIFESOLUTIONS
  • LIFELINE SCIENTIFIC
  • BIOCISION, CESCA THERAPEUTICS, INC
  • CORE DYNAMICS GMBH
  • CUSTOM BIOGENIC SYSTEMS
  • ATLANTA BIOLOGICS PVT. LTD
  • TAYLOR-WHARTON
  • PANASONIC HOLDINGS CORPORATION

第12章 付録

図表

LIST OF TABLES

  • TABLE 1 GLOBAL TISSUE BANKING MARKET, SYNOPSIS, 2019-2030
  • TABLE 2 GLOBAL TISSUE BANKING MARKET, ESTIMATES & FORECAST, 2019-2030 (USD BILLION)
  • TABLE 3 GLOBAL TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 4 GLOBAL TISSUE BANKING MARKET, BY TISSUE TYPE, 2019-2030 (USD BILLION)
  • TABLE 5 GLOBAL TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 6 NORTH AMERICA: TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 7 NORTH AMERICA: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019-2030 (USD BILLION)
  • TABLE 8 NORTH AMERICA: TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 9 US: TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 10 US: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019-2030 (USD BILLION)
  • TABLE 11 US: TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 12 CANADA: TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 13 CANADA: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019-2030 (USD BILLION)
  • TABLE 14 CANADA: TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 15 EUROPE: TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 16 EUROPE: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019-2030 (USD BILLION)
  • TABLE 17 EUROPE: TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 18 GERMANY: TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 19 GERMANY: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019-2030 (USD BILLION)
  • TABLE 20 GERMANY: TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 21 FRANCE: TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 22 FRANCE: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019-2030 (USD BILLION)
  • TABLE 23 FRANCE: TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 24 ITALY: TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 25 ITALY: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019-2030 (USD BILLION)
  • TABLE 26 ITALY: TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 27 SPAIN: TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 28 SPAIN: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019-2030 (USD BILLION)
  • TABLE 29 SPAIN: TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 30 UK: TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 31 UK: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019-2030 (USD BILLION)
  • TABLE 32 UK: TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 33 REST OF EUROPE: TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 34 REST OF EUROPE: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019-2030 (USD BILLION)
  • TABLE 35 REST OF EUROPE: TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 36 ASIA-PACIFIC: TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 37 ASIA-PACIFIC: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019-2030 (USD BILLION)
  • TABLE 38 ASIA-PACIFIC: TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 39 JAPAN: TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 40 JAPAN: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019-2030 (USD BILLION)
  • TABLE 41 JAPAN: TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 42 CHINA: TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 43 CHINA: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019-2030 (USD BILLION)
  • TABLE 44 CHINA: TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 45 INDIA: TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 46 INDIA: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019-2030 (USD BILLION)
  • TABLE 47 INDIA: TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 48 AUSTRALIA: TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 49 AUSTRALIA: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019-2030 (USD BILLION)
  • TABLE 50 AUSTRALIA: TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 51 SOUTH KOREA: TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 52 SOUTH KOREA: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019-2030 (USD BILLION)
  • TABLE 53 SOUTH KOREA: TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 54 REST OF ASIA-PACIFIC: TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 55 REST OF ASIA-PACIFIC: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019-2030 (USD BILLION)
  • TABLE 56 REST OF ASIA-PACIFIC: TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 57 REST OF THE WORLD: TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 58 REST OF THE WORLD: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019-2030 (USD BILLION)
  • TABLE 59 REST OF THE WORLD: TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 60 MIDDLE EAST: TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 61 MIDDLE EAST: TISSUE BANKING MARKET, BY THERAPY, 2019-2030 (USD BILLION)
  • TABLE 62 MIDDLE EAST: TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 63 AFRICA: TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 64 AFRICA: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019-2030 (USD BILLION)
  • TABLE 65 AFRICA: TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 66 LATIN AMERICA: TISSUE BANKING MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 67 LATIN AMERICA: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019-2030 (USD BILLION)
  • TABLE 68 LATIN AMERICA: TISSUE BANKING MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

LIST OF FIGURES

  • FIGURE 1 RESEARCH PROCESS
  • FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL TISSUE BANKING MARKET
  • FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL TISSUE BANKING MARKET
  • FIGURE 4 GLOBAL TISSUE BANKING MARKET, SHARE (%), BY TYPE , 2022
  • FIGURE 5 GLOBAL TISSUE BANKING MARKET, SHARE (%), BY TISSUE TYPE, 2022
  • FIGURE 6 GLOBAL TISSUE BANKING MARKET, SHARE (%), BY APPLICATION, 2022
  • FIGURE 7 GLOBAL TISSUE BANKING MARKET, SHARE (%), BY REGION, 2022
  • FIGURE 8 NORTH AMERICA: TISSUE BANKING MARKET, SHARE (%), BY REGION, 2022
  • FIGURE 9 EUROPE: TISSUE BANKING MARKET, SHARE (%), BY REGION, 2022
  • FIGURE 10 ASIA-PACIFIC: TISSUE BANKING MARKET, SHARE (%), BY REGION, 2022
  • FIGURE 11 REST OF THE WORLD: TISSUE BANKING MARKET, SHARE (%), BY REGION, 2022
  • FIGURE 12 GLOBAL TISSUE BANKING MARKET: COMPANY SHARE ANALYSIS (%), 2022
  • FIGURE 13 THERMO FISHER SCIENTIFIC INC : FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 14 THERMO FISHER SCIENTIFIC INC : SWOT ANALYSIS
  • FIGURE 15 ASTRAZENECA: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 16 ASTRAZENECA: SWOT ANALYSIS
  • FIGURE 17 BIOLIFESOLUTIONS: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 18 BIOLIFESOLUTIONS: SWOT ANALYSIS
  • FIGURE 19 LIFELINE SCIENTIFIC : FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 20 LIFELINE SCIENTIFIC : SWOT ANALYSIS
  • FIGURE 21 BIOCISION, CESCA THERAPEUTICS, INC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 22 BIOCISION, CESCA THERAPEUTICS, INC: SWOT ANALYSIS
  • FIGURE 23 CORE DYNAMICS GMBH : FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 24 CORE DYNAMICS GMBH : SWOT ANALYSIS
  • FIGURE 25 CUSTOM BIOGENIC SYSTEMS : FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 26 CUSTOM BIOGENIC SYSTEMS : SWOT ANALYSIS
  • FIGURE 27 ATLANTA BIOLOGICS PVT. LTD: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 28 ATLANTA BIOLOGICS PVT. LTD: SWOT ANALYSIS
  • FIGURE 29 TAYLOR-WHARTON : FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 30 TAYLOR-WHARTON : SWOT ANALYSIS
  • FIGURE 31 PANASONIC HOLDINGS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 32 PANASONIC HOLDINGS CORPORATION: SWOT ANALYSIS
目次
Product Code: MRFR/HC/10884-HCR

Market Overview

Tissue Banking Market is anticipated to register a healthy CAGR of 8.5% during the review period.

The rising predominance of constant sicknesses like malignant growth, coronary illness, and diabetes infection significantly influence all around the world as well as raises the interest for cutting edge treatment options for the treatment of persistent sickness. As rising gamble of constant sickness appears to be the best treatment elective for tissue banking. What's more, according to the American Malignant growth Society, around 1.9 million new instances of disease were analysed in the US. Moreover, coronary illness is considered as the main source of death for ladies and men. One individual kick the bucket like clockwork in the US from cardiovascular illness. Around 4,66,566 individuals experienced coronary illness in the US. Coronary illness costs the US around USD 239.9 billion consistently from 2018 to 2019. Hence, the rising commonness of coronary illness disease, and diabetes is expanding the interest in tissue banking so central participants are distinctly interested in the research and improvement movement for new item advancement which pushes the development of tissue banking.

Market Segmentation

The Tissue Banking Market segmentation, based on type, includes media and consumable, cryopreservation equipment, thawing equipment, quality control equipment, and others.

The Tissue Banking Market segmentation is based on tissue types that include heart valve, cornea, bone, skin, brain & spinal cord, and others.

The Tissue Banking Market segmentation is based on applications that include therapeutics, medical research, and others.

Regional Insights

North America represented the biggest market share in 2022 attributable to the North America is supposed to order the biggest market share because of the rising propensity of egg frozen in the US, accessibility of advance innovation, expanding medical care framework, created monetary condition boos the development of tissue banking in the North America region.

Europe tissue banking market is supposed to represent the second-biggest market share because of the development of the market are expanding mechanical turn of events and item advancement, rising research and improvement movement, expanding event of life threating sickness like coronary illness, malignant growth, and others. Moreover, expanding quantities of organ contributors across the region is driving the development of tissue banking.

The Asia-Pacific tissue banking market is anticipated to register a CAGR of 6.90% during the review period. This is because of expanding venture by unfamiliar organizations, colossal ongoing sickness populace, expanding entrance of frozen eggs are driving the development of tissue banking in the Asia-pacific region.

Latin America holds the significant market share in the middle east and Africa region because of the region's development is credited to a developing utilization of tissue banking, rising mindfulness about the organ gift for saving other life, developing new mechanical turn of events and advance clinical office across the region are help the development of tissue banking in region.

Major Players

The key market players are Applied Biosystems, Custom Biogenic Systems (US), Invitrogen, Thermo Scientific, Fisher Scientific, Cesca Therapeutics, Inc. (US), Unity Lab Services, BioLife Solutions (US), Atlanta Biologics Pvt. Ltd. (US), Lifeline Scientific (US), BioCision, core dynamics GmbH (US), Taylor-Wharton (US), and Panasonic Holdings Corporation (Japan).

TABLE OF CONTENTS

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

  • 1.1. MARKET ATTRACTIVENESS ANALYSIS
    • 1.1.1. GLOBAL TISSUE BANKING MARKET, BY TYPE
    • 1.1.2. GLOBAL TISSUE BANKING MARKET, BY TISSUE TYPE
    • 1.1.3. GLOBAL TISSUE BANKING MARKET, BY APPLICATION
    • 1.1.4. GLOBAL TISSUE BANKING MARKET, BY REGION

2. MARKET INTRODUCTION

  • 2.1. DEFINITION
  • 2.2. SCOPE OF THE STUDY
  • 2.3. MARKET STRUCTURE

3. RESEARCH METHODOLOGY

  • 3.1. OVERVIEW
  • 3.2. DATA MINING
  • 3.3. SECONDARY RESEARCH
  • 3.4. PRIMARY RESEARCH
    • 3.4.1. PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
    • 3.4.2. BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.5. FORECASTING TECHNIQUE
  • 3.6. MARKET SIZE ESTIMATION
    • 3.6.1. BOTTOM-UP APPROACH
    • 3.6.2. TOP-DOWN APPROACH
  • 3.7. DATA TRIANGULATION
  • 3.8. VALIDATION

4. MARKET DYNAMICS

  • 4.1. INTRODUCTION
  • 4.2. DRIVERS
  • 4.3. RESTRAINTS
  • 4.4. OPPORTUNITIES

5. MARKET FACTOR ANALYSIS

  • 5.1. VALUE CHAIN ANALYSIS
  • 5.2. PORTER'S FIVE FORCES ANALYSIS
    • 5.2.1. BARGAINING POWER OF SUPPLIERS
    • 5.2.2. BARGAINING POWER OF BUYERS
    • 5.2.3. THREAT OF NEW ENTRANTS
    • 5.2.4. THREAT OF SUBSTITUTES
    • 5.2.5. INTENSITY OF RIVALRY
  • 5.3. COVID-19 IMPACT ANALYSIS
    • 5.3.1. MARKET IMPACT ANALYSIS
    • 5.3.2. REGIONAL IMPACT
    • 5.3.3. OPPORTUNITY AND THREAT ANALYSIS

6. GLOBAL TISSUE BANKING MARKET, BY TYPE

  • 6.1. OVERVIEW
  • 6.2. MEDIA AND CONSUMABLE
  • 6.3. CRYOPRESERVATION EQUIPMENT
  • 6.4. THAWING EQUIPMENT
  • 6.5. QUALITY CONTROL EQUIPMENT
  • 6.6. OTHERS

7. GLOBAL TISSUE BANKING MARKET, BY TISSUE TYPE

  • 7.1. OVERVIEW
  • 7.2. HEART VALVE
  • 7.3. CORNEA
  • 7.4. BONE
  • 7.5. SKIN
  • 7.6. BRAIN & SPINAL CORD
  • 7.7. OTHERS

8. GLOBAL TISSUE BANKING MARKET, BY APPLICATION

  • 8.1. OVERVIEW
  • 8.2. THERAPEUTICS
  • 8.3. MEDICAL RESEARCH
  • 8.4. OTHERS

9. GLOBAL TISSUE BANKING MARKET, BY REGION

  • 9.1. OVERVIEW
  • 9.2. NORTH AMERICA
    • 9.2.1. US
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. FRANCE
    • 9.3.3. UK
    • 9.3.4. ITALY
    • 9.3.5. SPAIN
    • 9.3.6. REST OF EUROPE
  • 9.4. ASIA-PACIFIC
    • 9.4.1. CHINA
    • 9.4.2. INDIA
    • 9.4.3. JAPAN
    • 9.4.4. AUSTRALIA
    • 9.4.5. SOUTH KOREA
    • 9.4.6. REST OF ASIA-PACIFIC
  • 9.5. REST OF THE WORLD
    • 9.5.1. MIDDLE EAST
    • 9.5.2. AFRICA
    • 9.5.3. LATIN AMERICA

10. COMPETITIVE LANDSCAPE

  • 10.1. INTRODUCTION
  • 10.2. COMPETITIVE ANALYSIS
  • 10.3. MARKET SHARE ANALYSIS
  • 10.4. MAJOR GROWTH STRATEGY IN THE GLOBAL TISSUE BANKING MARKET
  • 10.5. COMPETITIVE BENCHMARKING
  • 10.6. LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL TISSUE BANKING MARKET
  • 10.7. KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 10.7.1. NEW PRODUCT LAUNCH
    • 10.7.2. MERGER & ACQUISITION
    • 10.7.3. JOINT VENTURES
  • 10.8. MAJOR PLAYERS FINANCIAL MATRIX
    • 10.8.1. SALES & OPERATING INCOME, 2022
    • 10.8.2. MAJOR PLAYERS R&D EXPENDITURE, 2022

11. COMPANY PROFILES

  • 11.1. THERMO FISHER SCIENTIFIC INC
    • 11.1.1. COMPANY OVERVIEW
    • 11.1.2. FINANCIAL OVERVIEW
    • 11.1.3. TYPES OFFERED
    • 11.1.4. KEY DEVELOPMENTS
    • 11.1.5. SWOT ANALYSIS
    • 11.1.6. KEY STRATEGIES
  • 11.2. BIOLIFESOLUTIONS
  • 11.3. LIFELINE SCIENTIFIC
  • 11.4. BIOCISION, CESCA THERAPEUTICS, INC
  • 11.5. CORE DYNAMICS GMBH
  • 11.6. CUSTOM BIOGENIC SYSTEMS
  • 11.7. ATLANTA BIOLOGICS PVT. LTD
  • 11.8. TAYLOR-WHARTON
  • 11.9. PANASONIC HOLDINGS CORPORATION

12. APPENDIX

  • 12.1. REFERENCE REPORT
  • 12.2. RELATED REPORTS